Zoltan Beck

U.S. Military HIV Research Program, Walter Reed Army Institute of Research

Affiliated withWalter Reed Army Institute of Research Henry M. Jackson Foundation for the Advancement of Military Medicine

Research Area

Bioengineering

Biography

Zoltan Beck has not added Biography.
If you are Zoltan Beck and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 4	2019

Other Publications

Article	Year
HIV-1, lipid rafts, and antibodies to liposomes: implications for anti-viral-neutralizing antibodies. Molecular membrane biology\| PubMed ID: 17127618	2006
Monoclonal antibodies to phosphatidylinositol phosphate neutralize human immunodeficiency virus type 1: role of phosphate-binding subsites. Journal of virology\| PubMed ID: 17151131	2007
Antibodies induced by liposomal protein exhibit dual binding to protein and lipid epitopes. Biochemical and biophysical research communications\| PubMed ID: 18088597	2008
Lipid binding properties of 4E10, 2F5, and WR304 monoclonal antibodies that neutralize HIV-1. Biochimica et biophysica acta\| PubMed ID: 19100711	2009
Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes. AIDS (London, England)\| PubMed ID: 19710597	2009
Human erythrocytes selectively bind and enrich infectious HIV-1 virions. PloS one\| PubMed ID: 20011536	2009
Infection of human peripheral blood mononuclear cells by erythrocyte-bound HIV-1: effects of antibodies and complement. Virology\| PubMed ID: 21334707	2011
Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs. Vaccine\| PubMed ID: 23624097	2013
Platelets and erythrocyte-bound platelets bind infectious HIV-1 in plasma of chronically infected patients. PloS one\| PubMed ID: 24282562	2013
Facial recognition of heroin vaccine opiates: type 1 cross-reactivities of antibodies induced by hydrolytically stable haptenic surrogates of heroin, 6-acetylmorphine, and morphine. Vaccine\| PubMed ID: 24486371	2014
Synthesis and immunological effects of heroin vaccines. Organic & biomolecular chemistry\| PubMed ID: 24995943	2014
Adjuvants for vaccines to drugs of abuse and addiction. Vaccine\| PubMed ID: 25111169	2014
Detection of liposomal cholesterol and monophosphoryl lipid A by QS-21 saponin and Limulus polyphemus amebocyte lysate. Biochimica et biophysica acta\| PubMed ID: 25511587	2015
Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers. Bioconjugate chemistry\| PubMed ID: 25970207	2015
Differential immune responses to HIV-1 envelope protein induced by liposomal adjuvant formulations containing monophosphoryl lipid A with or without QS21. Vaccine\| PubMed ID: 26372857	2015
Liposomal adjuvants for human vaccines. Expert opinion on drug delivery\| PubMed ID: 26866300	2016
Development of a self-assembling protein nanoparticle vaccine targeting Plasmodium falciparum Circumsporozoite Protein delivered in three Army Liposome Formulation adjuvants. Vaccine\| PubMed ID: 28274638	2017
Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013. Vaccine\| PubMed ID: 28596090	2017
A Stable Heroin Analogue That Can Serve as a Vaccine Hapten to Induce Antibodies That Block the Effects of Heroin and Its Metabolites in Rodents and That Cross-React Immunologically with Rel... Journal of medicinal chemistry\| PubMed ID: 29236495	2018
Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant. NPJ vaccines\| PubMed ID: 29263870	2017
Immune response to antigen adsorbed to aluminum hydroxide particles: Effects of co-adsorption of ALF or ALFQ adjuvant to the aluminum-antigen complex. Journal of controlled release : official journal of the Controlled Release Society\| PubMed ID: 29432824	2018
Self-Assembling Protein Nanoparticles: implications for HIV-1 vaccine development. Nanomedicine (London, England)\| PubMed ID: 30270731	2018
Saturated phospholipids are required for nano- to micron-size transformation of cholesterol-containing liposomes upon QS21 addition. Journal of liposome research\| PubMed ID: 30350748	2019
Design and characterization of a self-assembling protein nanoparticle displaying HIV-1 Env V1V2 loop in a native-like trimeric conformation as vaccine antigen. Nanomedicine : nanotechnology, biology, and medicine\| PubMed ID: 30576800	2019
Glycosylation of the HIV-1 Env V1V2 loop to form a native-like structure may not be essential with a nanoparticle vaccine. Future virology\| PubMed ID: 30815025	2019
Enhanced Immunogenicity and Protective Efficacy of a Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21. mSphere\| PubMed ID: 31043512	2019
Correction for Ramakrishnan et al., "Enhanced Immunogenicity and Protective Efficacy of a Campylobacter jejuni Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid... mSphere\| PubMed ID: 31118306	2019
Safety, toxicity and immunogenicity of a malaria vaccine based on the circumsporozoite protein (FMP013) with the adjuvant army liposome formulation containing QS21 (ALFQ). Vaccine\| PubMed ID: 31151801	2019
Particle size analyses of polydisperse liposome formulations with a novel multispectral advanced nanoparticle tracking technology. International journal of pharmaceutics\| PubMed ID: 31176851	2019
Erratum for Ramakrishnan et al., "Enhanced Immunogenicity and Protective Efficacy of a Campylobacter jejuni Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A ... mSphere\| PubMed ID: 31243083	2019